Calcium channel antagonists in the treatment of interstitial cystitis.
The calcium channel antagonist nifedipine has shown efficacy in the treatment of interstitial cystitis and the urethral syndrome. The optimal daily dose of nifedipine can be determined with the use of a nifedipine titration test. To complete the repair of damaged bladder and/or urethral mucosa, nifedipine therapy should be used for a minimum of 3 months. Patients who do not respond well to nifedipine are those with the pelvic floor muscle spasm syndrome variant of interstitial cystitis.
Fleischmann
J
J
Department of Urology, Albert Einstein College of Medicine, Bronx, New York.
D003556:Cystitis / Q000188:drug therapy*; D006801:Humans; D009543:Nifedipine / Q000627:therapeutic use*; D016896:Treatment Outcome
D009543:Nifedipine